Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia
- 12 January 2015
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 45 (1) , 86-93
Abstract
Background: Healthcare professional (HCP) time supporting insulin pump therapy (IPT) has not been documented, yet it is important in planning and allocating resources for effective care.Aim: This study aims to determine HCP time spent in IPT patient care to inform resource planning for optimal IPT delivery.Methods: Twenty‐four Australian adult IPT‐experienced institutions (14 government funded, seven private, three both) collected data between April 2012 and January 2013 prospectively, including: patient demographics, HCP classification, purpose of HCP–patient interaction, interaction mode and HCP time with the patient. A subset of patients was tracked from pre‐pump education until stable on IPT.Results: Data on 2577 HCP‐adult patient interactions (62% face‐to‐face, 29% remote, 9% administrative) were collected over 12.2 ± 6.4 weeks for 895 patients; age 35.4 ± 14.2 years; 67% female; 99% type 1 diabetes, representing 25% of all IPT patients of the institutions. Time (hours) spent on IPT interactions per centre per week were: nurses 5.4 ± 2.8, dietitians 0.4 ± 0.2 and doctors 1.0 ± 0.5. IPT starts accounted for 48% of IPT interaction time. The percentage of available diabetes clinic time spent on outpatient IPT interactions was 20.4%, 4.6% and 2.7% for nurses, dietitians and doctors respectively. Fifteen patients tracked from pre‐pump to stabilisation over 11.8 ± 4.5 weeks, required a median (range) of 9.2 (3.0–20.9), 2.4 (0.5–6.0) and 1.8 (0.5–5.4) hours per patient from nurses, dietitians and doctors respectively.Conclusions: IPT patient care represents a substantial investment in HCP time, particularly for nurses. Funding models for IPT care need urgent review to ensure this now mainstream therapy integrates well into healthcare resources.Keywords
This publication has 10 references indexed in Scilit:
- Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control studyDiabetologia, 2013
- Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluationHealth Technology Assessment, 2010
- Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007Diabetologia, 2009
- Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of InsulinPharmacoEconomics, 2007
- Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trialDiabetic Medicine, 2005
- Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UKDiabetic Medicine, 2005
- The cost‐effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetesDiabetic Medicine, 2003
- Insulin Pump TherapyDiabetes Care, 2003
- Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trialsBMJ, 2002
- Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I DiabetesDiabetes Care, 1996